Respiratory Endotherapy Devices Market

Respiratory Endotherapy Devices Market: Introduction

Respiratory endotherapy devices are used to diagnose and treat pulmonary diseases such as tuberculosis, asthma, COPD, bronchitis, emphysema, interstitial lung diseases, tumors of the lung, pulmonary embolism, asthma and related disorders.

Cystic fibrosis and pulmonary asthma are the most common forms of lung disorders found all over the world. Pulmonologists use the devices to detect respiratory diseases. Doctors perform the majority of bronchoscopy procedures. A thin tube is inserted via the nose or mouth, then throat, and lastly, taken up to the lungs. Thus, increase in the number of pulmonary patients is anticipated to fuel the respiratory endotherapy devices market.

Key Drivers, Restrains, and Opportunities of Respiratory Endotherapy Devices Market

• Increase in prevalence in respiratory disease and rise in geriatric population has augmented the global demand for endoscopy equipment, boosting the respiratory endotherapy devices market
• Technological advancements have increased the demand for respiratory endotherapy, especially fibrotic bronchoscopy, which is likely to further generate lucrative opportunities for pulmonary market.
• Olympus’ endoscope technologies will combine with VMT’s navigation products to develop solutions for improved diagnosis of peripheral lung cancer. The company had an agreement to obtain Veran Medical Technologies, Inc. (VMT), which is a leading provider of advanced medical devices specializing in international pulmonology.
• Need for definitive diagnosis of lesions in the peripheral regions of the lungs by tissue biopsy is expected to increase due to rise in awareness of lung cancer screenings done by CT (computed tomography). VMT's navigational platform and proprietary devices are anticipated to get support for the same by combining with Olympus technology.
• Government regulations related to complications in endoscopy are likely to have a severe impact on business growth. The loss of sales has impacted negatively on new product development.

North America to Capture Major Share of Respiratory Endotherapy Devices Market

The market in North America is driven by an increase in number of lung disorders and lower preference for invasive surgical procedures. The U.S. FDA has permitted the Zephyr Endobronchial Valve System for treating severe emphysema patients. The Zephyr Valve is the first minimally invasive device approved in the U.S. for treating patients with severe emphysema, a progressive and deadly form of chronic obstructive pulmonary disease (COPD).

Economic growth in Asia Pacific can be ascribed to significant expansion in the healthcare infrastructure in developing countries such as China, India & other East Asian countries. The market in Asia Pacific is driven by the rising prevalence of respiratory disorders such as chronic obstructive pulmonary disease (COPD), TB, asthma, and sleep apnea; technological advancements; increasing applications in the in-home care setting and growing geriatric population.

Key Players Operating in Respiratory Endotherapy Devices Market

The global respiratory endotherapy devices market is fragmented due to the presence of international as well as local players. A large number of manufacturers hold major shares in their respective regions. Demand for respiratory endotherapy devices has increased in emerging as well as developed markets due to rise in awareness about technologically advanced products. Growth strategies adopted by leading players are likely to drive the global market. Key players operating in the global respiratory endotherapy devices market are listed below:

• Fujifilm Holdings corporation
• Medtronic
• Johnson & Johnson
• Smith & Nephew Plc.
• Stryker corporation
• Olympus
• Hoya corporation
• Steris Healthcare
• Conmed
• Boston corporation
• Vimex

Respiratory Endotherapy Devices Market: Research Scope

 Respiratory Endotherapy Devices Market, by Device Type

• Diagnostic Devices
• Biopsy forceps
• Cytology Brushes
• Trans Bronchial aspiration
• Therapeutic Devices
• Pulmonary Balloon Dilation Catheter
• Airway Retrieved Basket
• Tracheobronchial stents
• Pulmonary stent system
• Airway stent
• Bifurcated Trachea
• Branchial Stent
• Bronchial Thermoplasty
• Bronchial thermoplasty system

 Respiratory Endotherapy Devices Market, by End-user

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers

Respiratory Endotherapy Devices Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia & New Zealand
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa